Thus, more samples and detailed clinical information should be collected to evaluate the prognostic value of PXN. Third, the potential application of PXN as a reliable prognostic factor or promising therapeutic target for GBM must be assessed via extensive clinical studies in the future. Here, PXN is linked to glioblastoma.